← Back to Search

Cannabinoid Receptor Agonist

Opioid Use Disorder for Opioid Use Disorder

Phase 1

Recruiting

Led By Anahita Bassir Nia, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one time within 4 weeks of screening

Awards & highlights

Summary

The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.

Eligible Conditions

Opioid Use Disorder
Healthy Controls

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one time within 4 weeks of screening

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one time within 4 weeks of screening

This trial's timeline: 3 weeks for screening, Varies for treatment, and one time within 4 weeks of screening for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

CB1R Availability

Secondary study objectives

Serum Endocannabinoid Levels

Trial Design

2Treatment groups

Experimental Treatment

Group I: Opioid Use DisorderExperimental Treatment1 Intervention

Patients diagnosed with opioid use disorder

Group II: Healthy VolunteersExperimental Treatment1 Intervention

Healthy volunteers with no current or past major medical or psychiatric history

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,543 Previous Clinical Trials

3,249,346 Total Patients Enrolled

Yale UniversityLead Sponsor

1,907 Previous Clinical Trials

3,019,019 Total Patients Enrolled

Anahita Bassir Nia, MDPrincipal InvestigatorYale University

2 Previous Clinical Trials

78 Total Patients Enrolled

~13 spots leftby Dec 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.